Ignite Creation Date:
2024-05-06 @ 3:33 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04674345
Status:
UNKNOWN
Last Update Posted:
2021-11-08
First Post:
2020-12-14
Brief Title:
Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Organization Data
Organization:
Nanfang Hospital Southern Medical University
Class:
OTHER
Study ID:
Sorafenib-Non-Flt3 AL-2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanfang Hospital Southern Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Qifa Liu
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanfang Hospital Southern Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Seventh Affiliated Hospital of Sun Yat-sen University | OTHER |
| Peking University Peoples Hospital | OTHER |
| Xiangya Hospital of Central South University | OTHER |
| Zhujiang Hospital | OTHER |
| Third Affiliated Hospital Sun Yat-Sen University | OTHER |
| First Peoples Hospital of Chenzhou | OTHER |
| The First Affiliated Hospital of Guangzhou Medical University | OTHER |
| The Third Xiangya Hospital of Central South University | OTHER |
| Second Affiliated Hospital Sun Yat-Sen University | OTHER |